Saikat Mitra

Dr. Saikat Mitra

National University Hospital, Singapore
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SMSaikat Mitra
Saikat Mitra
RLRyan Ruiyang Ling
Ryan Ruiyang Ling
CTChuen Seng Tan
Chuen Seng Tan
KSKiran Shekar
Kiran Shekar
GMGraeme MacLaren
Graeme MacLaren
KRKollengode Ramanathan
Kollengode Ramanathan
Patients supported with extracorporeal membrane oxygenation (ECMO) often receive renal replacement therapy (RRT). We conducted this systematic review and meta-analysis (between January 2000 and September 2020) to assess outcomes in patients who received RRT on ECMO. Random-effects meta-analyses were performed using R 3.6.1 and certainty of evidence was rated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. The primary outcome was pooled mortality. The duration of ECMO support and ICU/hospital lengths of stay were also investigated. Meta-regression analyses identified factors associated with mortality. A total of 5896 adult patients (from 24 observational studies and 1 randomised controlled trial) were included in this review. Overall pooled mortality due to concurrent use of RRT while on ECMO from observational studies was 63.0% (95% CI: 56.0–69.6%). In patients receiving RRT, mortality decreased by 20% in the last five years; the mean duration of ECMO support and ICU and hospital lengths of stay were 9.33 days (95% CI: 7.74–10.92), 15.76 days (95% CI: 12.83–18.69) and 28.47 days (95% CI: 22.13–34.81), respectively, with an 81% increased risk of death (RR: 1.81, 95% CI: 1.56–2.08, p < 0.001). RRT on ECMO was associated with higher mortality rates and a longer ICU/hospital stay compared to those without RRT. Future research should focus on minimizing renal dysfunction in ECMO patients and define the optimal timing of RRT initiation.

27 May 2022 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
JSJackie Sim
Jackie Sim
SMSaikat Mitra
Saikat Mitra
RLRyan Ruiyang Ling
Ryan Ruiyang Ling
CTChuen Seng Tan
Chuen Seng Tan
Bingwen Eugene FanBingwen Eugene Fan
Bingwen Eugene Fan
KRKollengode Ramanathan
Kollengode Ramanathan

10 October 2021 in Transfusion Medicine Reviews
Verified
Journal Article
Closed access
RLRyan Ruiyang Ling
Ryan Ruiyang Ling
JSJackie Jia Lin Sim
Jackie Jia Lin Sim
FTFelicia Liying Tan
Felicia Liying Tan
BTBee Choo Tai
Bee Choo Tai
NSNicholas Syn
Nicholas Syn
KRKollengode Ramanathan
Kollengode Ramanathan

26 October 2022 in ASAIO Journal
Verified
Journal Article
Closed access
ENEmily Shu Ting Ng
Emily Shu Ting Ng
RLRyan Ruiyang Ling
Ryan Ruiyang Ling
SMSaikat Mitra
Saikat Mitra
CTChuen Seng Tan
Chuen Seng Tan
GMGraeme MacLaren
Graeme MacLaren
KRKollengode Ramanathan
Kollengode Ramanathan
Burns are among the leading causes of trauma worldwide, and acute respiratory distress syndrome (ARDS) is a common cause of death in burn patients. Some patients develop hypoxemia refractory to conventional therapies and may be initiated on extracorporeal membrane oxygenation (ECMO) as rescue therapy. We conducted a meta-analysis for studies reporting on survival rates of patients receiving ECMO for burns or inhalation injuries, which was the primary outcome. Secondary outcomes included the hospital and intensive care unit length of stay and duration of ECMO. Random-effects (DerSimonian and Laird) were conducted. The pooled survival from 10 studies was 53.6% (95% confidence interval [CI]: 37.6–69.2%, high certainty). Survival was significantly associated with age (regression coefficient [B]: −0.0088, 95% CI: −0.0155 to −0.0021, p = 0.011) and the proportion of male patients (B: −1.0137 95% CI: −1.9695 to −0.0580, p = 0.038). Patients were cannulated on ECMO for a mean of 8.4 days (95% CI: 6.1–10.7) and remained in the ICU for a mean of 40.4 days (95% CI: 11.4–69.3). Mean hospital length of stay was 45.4 days (95% CI: 31.7–59.0). In conclusion, patients with burn and inhalation injuries who develop ARDS refractory to conservative management have a survival rate of 54% when placed on ECMO.

1 July 2022 in Australian Critical Care
Verified
Journal Article
Closed access
ASAshwin Subramaniam
Ashwin Subramaniam
MRMallikarjuna Ponnapa Reddy
Mallikarjuna Ponnapa Reddy
UKUmesh Kadam
Umesh Kadam
AZAlexander Zubarev
Alexander Zubarev
ZLZheng Lim
Zheng Lim
KSKiran Shekar
Kiran Shekar

1 January 2015 in Indian Journal of Anaesthesia
Verified
Journal Article
Open access
PDF file
SMSaikat Mitra
Saikat Mitra
SPShobha Purohit
Shobha Purohit
SBSonali Bhatia
Sonali Bhatia
PKPoonam Kalra
Poonam Kalra
SSSatya Prakash Sharma
Satya Prakash Sharma
Background and Aims: Rocuronium may not always be the preferred relaxant for rapid sequence intubation. When 2% sevoflurane is used in conjunction with rocuronium, it may reduce the time required for achieving complete skeletal muscle relaxation with the intubating dose of rocuronium. Methods: This study was prospective, randomised, double-blind in nature and compared the effect of sevoflurane on intubation time and intubating conditions when used along with rocuronium. Thirty adult patients belonging to American Society of Anesthesiologists physical status Grades 1 and 2, of either gender aged between 30 and 65 years undergoing neurosurgical operations were randomly allocated into two equal groups: Group R received 0.8 mg/kg rocuronium, and Group RS received 0.8 mg/kg of rocuronium with 2% sevoflurane. Onset time of intubation was assessed using train-of-four stimuli. The intubating conditions were compared using the Cooper scoring system and the haemodynamic responses were compared between the two groups. Results: The onset time of intubation was 101.73 ± 10.28 s in Group R and 60.4 ± 4.1 s in Group RS (P < 0.001), with excellent intubating conditions in both groups and without any adverse effects. Significant differences in heart rate and mean arterial pressure were seen immediately after intubation, at 1 and 3 min (P < 0.05) between the two groups. Conclusion: Rocuronium 0.8 mg/kg along with 2% sevoflurane provides excellent intubating conditions within 60-66 s from its administration.